Allergan, Inc.

From WikiMD's WELLNESSPEDIA

Allergan Headquarters

Allergan, Inc. is a global pharmaceutical company that focuses on developing, manufacturing, and commercializing branded pharmaceuticals, devices, and biologic products. The company was originally incorporated in 1948 as Allergan Pharmaceuticals, Inc., and later changed its name to Allergan, Inc. in 1989. It is headquartered in Dublin, Ireland.

History[edit]

Allergan, Inc. was founded by pharmacist Gavin S. Herbert and his partner, chemist Stanley Bly, in 1948. The company initially focused on the production of eye drops and contact lens solutions. In the 1950s, Allergan expanded its product line to include ophthalmic products and later diversified into neurology, dermatology, and aesthetics.

Products[edit]

Allergan's product portfolio includes leading brands such as Botox, Juvederm, and Restasis. Botox, a botulinum toxin, is used for various therapeutic and aesthetic treatments. Juvederm is a range of dermal fillers used for facial aesthetics. Restasis is an eye drop used to increase tear production in patients with chronic dry eye.

Acquisitions and Mergers[edit]

Over the years, Allergan has been involved in several acquisitions and mergers. In 2015, it was acquired by Actavis plc, a global pharmaceutical company, which subsequently adopted the Allergan name. In 2020, Allergan was acquired by AbbVie, a research-based global biopharmaceutical company.

Research and Development[edit]

Allergan's research and development efforts are focused on discovering and developing innovative medicines and therapies. The company has a strong pipeline of potential new products in various stages of development, particularly in the areas of eye care, neurology, and aesthetics.

Controversies[edit]

Allergan has faced several controversies, including lawsuits related to the safety and marketing of its products. The company has also been criticized for its pricing practices and for its use of a controversial patent protection strategy involving the Saint Regis Mohawk Tribe.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Allergan,_Inc.&oldid=6614190"